Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3171/2015.12.PEDS15710 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Common pulmonary vein atresia: a case report and treatment experience sharing of a newborn diagnosed with common pulmonary vein atresia after two operations.
Front Pediatr
August 2025
Department of Cardiac Surgery, Hebei Children's Hospital, Shijiazhaung, Hebei, China.
Common pulmonary vein atresia (CPVA) is a rare congenital heart disease characterized by the absence of functional connectivity between the pulmonary vein and any other heart cavity or systemic venous structure. A 13-h-old newborn (G3P3) was admitted to the department of pediatrics of a local maternity hospital and given tracheal intubation ventilator for assisted breathing due to systemic cyanosis, respiratory distress, and poor response 4 h after birth. He was transferred to Handan Maternal and Child Health Hospital 7 h after birth.
View Article and Find Full Text PDFIntegration of Patient Reported Outcomes Data among People with HIV in Washington, DC: A sub-cohort of the DC Cohort Longitudinal Study.
J Public Health (Berl)
July 2025
Department of Epidemiology, George Washington University (GWU), Washington, DC, USA.
Aim: Patient reported outcomes (PROs) can help to evaluate gaps and areas for improvement along the HIV care continuum. We sought to describe the methodology and processes of a PROs study within the DC Cohort study population, describe the PROs results to date, report on lessons learned, and describe future directions of the research.
Subject And Methods: Each study site recruited participants from the DC Cohort, a longitudinal study on people with HIV, to complete the electronic PROs baseline and annual follow-up surveys, which consisted of previously validated measures of social determinants of health, mental health, substance use, medication adherence, and other related measures.
Learning from inborn errors of immunity and secondary immune deficiencies about vaccine immunogenicity, efficacy and safety.
Clin Exp Immunol
September 2025
Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, B15 2TT.
Since its discovery in the late 18th Century, the role of vaccination in preventing death and disease has expanded across many infectious diseases and cancer. Key to our understanding of vaccine immunogenicity and efficacy is knowledge of the immune system itself. Inborn Errors of Immunity (IEI) represent a heterogeneous group of disorders characterised by impaired function of the immune system.
View Article and Find Full Text PDFUsing the Ottawa Model for Nursing Curriculum Renewal to align a baccalaureate nursing program with the 2021 AACN Essentials.
J Prof Nurs
September 2025
Wellstar School of Nursing, Kennesaw State University, 520 Parliament Garden Way NW, MDC 4102, Kennesaw, GA 30144, USA.
There is an urgent call to transform nursing education in response to evolving changes in healthcare. It is critical that nursing graduates are prepared to thrive and deliver care in complex environments to increasingly diverse populations. This article describes a nursing school's approach to achieve these goals and presents details of work completed during the early phases of curriculum revision to integrate the American Association of Colleges of Nursing's (AACN's) 2021 publication, The Essentials: Core Competencies for Professional Nursing Education, into the baccalaureate programs.
View Article and Find Full Text PDFFuture-Proofing European Pharmaceutical Regulatory and Market Access Practices Based on EU Learnings from the COVID-19 Pandemic: Insights from Multi-Stakeholder Interviews.
Ther Innov Regul Sci
September 2025
Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Introduction: During the COVID-19 pandemic, regulatory and market access actions were taken to expedite the market entry of COVID-19 medicines. This study aims to (i) capture multi-stakeholder views on these actions, and (ii) provide recommendations for future-proofing routine and health-emergency frameworks.
Methods: Semi-structured interviews were conducted with policy makers/advisors (i.